Vitalhub (TSE:VHI – Get Free Report) received a C$7.50 target price from Cormark in a note issued to investors on Monday, BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Cormark’s price target indicates a potential upside of 18.11% from the company’s previous close. Cormark also issued estimates for Vitalhub’s FY2025 earnings at $0.26 EPS.
Other analysts have also recently issued reports about the stock. Canaccord Genuity Group raised their price target on shares of Vitalhub from C$5.25 to C$5.50 and gave the stock a “buy” rating in a report on Tuesday, February 6th. Eight Capital raised their price target on shares of Vitalhub from C$5.00 to C$6.25 and gave the stock a “buy” rating in a report on Tuesday, February 6th.
Read Our Latest Stock Report on Vitalhub
Vitalhub Trading Up 5.8 %
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings data on Thursday, March 21st. The company reported C$0.03 EPS for the quarter, missing analysts’ consensus estimates of C$0.04 by C($0.01). The firm had revenue of C$13.60 million for the quarter, compared to analysts’ expectations of C$13.68 million. Vitalhub had a net margin of 8.66% and a return on equity of 5.78%. On average, equities research analysts anticipate that Vitalhub will post 0.1501823 earnings per share for the current year.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More
- Five stocks we like better than Vitalhub
- What Investors Need to Know About Upcoming IPOs
- Silicon Motion Proves That AI in Motion Stays in Motion
- What Are the U.K. Market Holidays? How to Invest and Trade
- Undervalued UnitedHealth Group Won’t Be For Long
- Want to Profit on the Downtrend? Downtrends, Explained.
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.